Non-cytotoxic protein conjugates

Details for Australian Patent Application No. 2005311098 (hide)

Owner Health Protection Agency Allergan, Inc.

Inventors Chaddock, John; Steward, Lance; Foster, Keith; Penn, Charles; Francis, Joseph; Aoki, K. Roger

Agent Griffith Hack

Pub. Number AU-B-2005311098

PCT Pub. Number WO2006/059105

Priority 0504964.8 10.03.05 GB; 0426394.3 01.12.04 GB; 0504966.3 10.03.05 GB

Filing date 1 December 2005

Wipo publication date 8 June 2006

Acceptance publication date 11 August 2011

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/059105 Priority application(s): WO2006/059105

11 August 2011 Application Accepted

  Published as AU-B-2005311098

8 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005311099-Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY

2005311086-Fusion proteins